Dr. Soliman Abdul Kader Fakeeh Hospital Co.

Dr. Soliman Abdul Kader Fakeeh Hospital Co.

TTADAWUL:4017
30.42
SAR
-1.28
(-4.04%)
0.84EPS
36.48P/E
8.45BMarket Cap
Nov 11Next Earn
Dr. Soliman Abdul Kader Fakeeh Hospital Co.
TADAWUL:4017
(Saudi Exchange)

Recent

price

30.42

P/E

ratio

36.48

div

yld

- -

ROIC.AI

2023
2024
2025
TTM
SAR
10.12
12.85
13.44
13.44
Revenue per Share
1.22
1.32
1.26
1.01
Basic EPS, GAAP
-0.64
-0.41
-0.33
0.54
Free Cash Flow per Basic Share
5
- -
0.3
- -
Dividend per Share
4.44
12.81
13.79
13.89
Book Value per Share
2.07
10.44
11.41
11.51
Tangible Book Value per Share
230
217
230
231
Basic Weighted Avg Shares
2,327
2,791
3,090
3,100
Sales/Revenue/Turnover
14.35
12.87
9.97
8.51
Operating Margin (%)
149
163
182
197
Depreciation Expense
280
288
290
232
Net Income, GAAP
8.91
8.15
11.53
13.4
Effective Tax Rate (%)
12.02
10.3
9.39
7.49
Profit Margin (%)
323
909
705
624
Working Capital
1,692
803
815
905
LT Debt
1,255
3,319
3,581
3,606
Total Equity
- -
8.54
6.06
4.95
Return on Invested Capital (%)
- -
10.09
8.2
6.87
Return on Capital (%)
- -
14.5
9.49
7.46
Return on Common Equity (%)

Capital Structure

SAR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
361
402
466
LT Borrowings
334
334
331
LT Finance Leases
481
542
574
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
230
230
230
Market Capitalization
7,843
7,783
8,446

Working Capital

SAR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,825
1,843
1,879
Cash, Cash Equivalents & STI
439
422
357
Accounts Receivable, Net
975
975
1,076
Inventories
196
206
215
Total Current Liabilities
1,119
1,114
1,256
Payables & Accruals
- -
- -
- -
ST Debt
361
402
466
Deferred Revenue
- -
- -
- -

Growth Rates

SAR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
7.89%
Free Cash Flow
- -
- -
-14.92%
Net Income, GAAP
- -
- -
0.91%
Sales/Revenue/Turnover
- -
- -
10.73%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
680
654
714
743
2,791
2025
701
812
778
799
3,090
2026
724
799
- -
- -
- -

Quarterly Earnings Per Share

SAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.32
0.23
0.44
0.32
1.32
2025
0.31
0.36
0.31
0.28
1.26
2026
0.17
0.25
- -
- -
- -

Quarterly Dividends Per Share

SAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.3
2026
- -
- -
- -
- -
- -
Business
Dr. Soliman Abdel Kader Fakeeh Hospital Company, trading as Fakeeh Care Group, is a premier integrated healthcare service provider in Saudi Arabia founded in 1978 and headquartered in Jeddah. It offers a comprehensive range of medical services including ambulatory care; secondary and tertiary hospital care; emergency medical services; specialized clinical services such as adult and pediatric neurosurgery, robotic surgery, urology, orthopedic surgery, and obesity-related anesthesia; as well as home healthcare services. The group operates a hub-and-spoke model ensuring seamless continuity of patient care and also administers academic healthcare programs, reinforcing its commitment to patient-centric care and medical excellence. Its geographic footprint spans major Saudi cities including Jeddah, Riyadh, Makkah, Madinah, and NEOM, and it has expanded into the UAE healthcare and medical education markets. Recent major developments include the acquisition of a 50.01% controlling stake in Diagnostics Elite Company, a Saudi-based teleradiology and imaging services provider, for SAR 70 million to integrate advanced diagnostic services into its healthcare platform. The company went public with an IPO on the Saudi Exchange in mid-2024, enhancing its financial capabilities to support expansive growth plans. It has undertaken significant capacity expansions including the launch of a new 200-bed tertiary care hospital in Madinah and further expansion in Makkah, alongside the acquisition and relaunch of a smart hospital in Riyadh. Fakeeh Care Group is also actively growing its bed capacity and healthcare facilities with new construction projects in various key regions to nearly triple its total bed capacity from 585 to over 1,600 beds by 2028, aligning with Saudi Arabia's Vision 2030 for healthcare privatization and modernization. The company operates through multiple subsidiaries, owns several hospitals and specialized medical centers, and continuously invests in incorporating digital transformation and innovative technologies across its facilities to maintain high standards of individualized health care for communities. Its product and service offerings cover a broad spectrum of medical specialties and extend to academic and training programs for healthcare professionals, positioning it as a leading healthcare institution in the region with a track record of more than four decades in patient care excellence.